COVID-19: Sterilization

The MO HealthNet Division (MHD) is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus. The virus has been named "SARS-CoV-2" and the disease it causes has been named "coronavirus disease 2019" (abbreviated "COVID-19").

MO HealthNet participants who are pregnant women may elect to have a tubal ligation ("elective sterilization") and this is a covered service. During this event, if a participant's elective sterilization procedure is rescheduled, MO HealthNet will ensure coverage of the surgery at the later date.

COVID-19: Additional Albuterol Inhalers as Preferred Products

The MO HealthNet Division (MHD) is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus.  The virus has been named "SARS-CoV-2" and the disease it causes has been named "coronavirus disease 2019" (abbreviated "COVID-19").

During this event, MHD is adding two additional albuterol inhalers as preferred products. The list of preferred beta adrenergic short acting inhalers is:

COVID-19: Pharmacy Signature Log Requirement

The MO HealthNet Division (MHD) is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus.  The virus has been named "SARS-CoV-2" and the disease it causes has been named "coronavirus disease 2019" (abbreviated "COVID-19").

For Pharmacy claims, MO HealthNet requires documentation of “offer to counsel” and also requires maintenance of a signature log to prove the prescription was delivered and received.  This requirement is in section 13.11.B of the MO HealthNet Pharmacy Provider Manual.

COVID-19: Registered Behavior Technician

The MO HealthNet Division (MHD) is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus.  The virus has been named "SARS-CoV-2" and the disease it causes has been named "coronavirus disease 2019" (abbreviated "COVID-19").

The MHD recognizes that testing centers that administer the test required for the Registered Behavior Technician® credential are closed as of March 16, 2020 due to COVID-19.

COVID-19: E-Prescribing

MO HealthNet has received several questions regarding telephoning a prescription for controlled substances due to the COVID19 Pandemic.

E-Prescribing is allowed for all schedules if in compliance with BNDD/DEA requirements.

The requirements of a telephoned controlled substance prescription are BNDD/DEA requirements and are not under the authority of MO HealthNet. For your reference, the requirements are below for a CII prescription to be called in to a pharmacy:

§1306.11 Requirement of prescription.

COVID-19: New email address for Providers

The MO HealthNet Division (MHD) is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus.  The virus has been named "SARS-CoV-2" and the disease it causes has been named "coronavirus disease 2019" (abbreviated "COVID-19").

An email address has been set up for provider questions related to billing for COVID-19 testing, treatment, services provided via telehealth, etc.

MO HealthNet will respond to these questions and track the inquiries to compile FAQ’s that will be posted on the Education/Training webpage.

Subscribe to All MO HealthNet Providers